Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2022

Dec 3, 2022

35221_dirs_2022-12-02_c6815654-990c-43af-a8b7-f91e828fa484.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-11-30

Reporting Person: PAVmed Inc. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-30 Common stock J 1145086 $1.8383 Acquired 40253331 Direct
2022-11-30 Common Stock J 197656 $2.7826 Acquired 40450987 Direct
2022-11-30 Common Stock J 221952 $2.4780 Acquired 40672939 Direct
2022-11-30 Common Stock J 331210 $1.6606 Acquired 41004149 Direct
2022-11-30 Common Stock J 1479326 $1.8383 Acquired 42483475 Direct

Footnotes

F1: Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement.